related quality of life (HRQOL) [4] [5] [6] but also for the negativity affectivity (depressive and anxious symptoms) reported by pediatric patients. [7] [8] [9] It may be hypothesized that the recurrent remitting and relapsing of inflammation in the gastrointestinal tract, along with the accompanying worrisome gastrointestinal symptoms, results in a chronic state of uncertainty in these pediatric patients, manifested in part by depressive and anxious symptoms, as well as a sustained state of gastrointestinal worry associated with the ongoing probability for potentially socially embarrassing and debilitating gastrointestinal symptoms. [10] [11] [12] [13] Previously, our group demonstrated that pediatric patients with IBD report a broad gastrointestinal symptoms profile when compared with age, sex, and race/ethnicity matched healthy controls using the multidimensional Pediatric Quality of Life Inventory (PedsQL) Gastrointestinal Symptoms Scales, 14 which are contained within the PedsQL Gastrointestinal Symptoms Module. 15 We further demonstrated that these pediatric patients with IBD report greater gastrointestinal worry when compared with age, sex, and race/ethnicity matched healthy controls using the PedsQL Gastrointestinal Worry Scales. 14 The construct of gastrointestinal worry initially emerged as a significant theme during the cognitive interviews of pediatric patients with functional and organic gastrointestinal diseases, including IBD, in the development of the PedsQL Gastrointestinal Symptoms Module. 16 The gastrointestinal worry of these pediatric patients was related to worrying about bowel movements and worrying about stomach pain, constructs subsequently measured by the 2 PedsQL Gastrointestinal Worry Scales. 14, 15, 17 Another theme that emerged during the cognitive interviews for the PedsQL Gastrointestinal Symptoms Module was the patient concern regarding the communication of their disease to significant others. 16 Patient communication of their disease and gastrointestinal symptoms to others, including health care providers, school personnel, peers, and parents, involves a complex decision-making process of the relative costs and benefits of disclosure and discussion. 18 Although previous studies with adult patient populations have suggested that talking about their disease to their health care provider may ameliorate in part patient disease-related anxiety, 19 there has been no research using patient-reported communication as a predictor of gastrointestinal worry in pediatric patients with IBD. Further unique to this study, no previous research has investigated the mediating role of patient communication as a mechanism or intervening variable in the relationship between patient-perceived gastrointestinal symptoms and gastrointestinal worry in pediatric patients with IBD.
To address this significant gap in the pediatric IBD literature, we tested the primary hypothesis that patient health communication in IBD was a significant mediating variable between the predictive effects of gastrointestinal symptoms on gastrointestinal worry. Based on our previous research demonstrating the predictive effects of gastrointestinal symptoms on overall HRQOL in pediatric patients with IBD, 20 we also explored a more complex conceptual multiple mediator model in which the effects of gastrointestinal symptoms on overall generic HRQOL was mediated in part by patient health communication and gastrointestinal worry.
METHODS

Pediatric Patients and Settings
Pediatric patients with Crohn's disease or ulcerative colitis based on ICD-9-CM Diagnosis Codes were recruited from 9 pediatric tertiary care gastroenterology clinical sites across the United States for the PedsQL Gastrointestinal Symptoms Module field test study (see Appendix, Supplemental Digital Content, http://links.lww.com/IBD/B477). 15 The PedsQL Gastrointestinal Symptoms Module field test study took place between March 2011 and November 2013. 15 This study describes distinct statistical analyses from the field test study database. 4, 14, 15, 17, [20] [21] [22] [23] [24] Multivariate models testing mediational effects predicting gastrointestinal worry using the Gastrointestinal Symptoms Scales and Communication Scale in IBD have not been previously delineated. Written parental informed consent and child assent (when age appropriate) were obtained. 15 The research protocol for the field test study was approved by the Institutional Review Board at each participating institution.
Measures
PedsQL Gastrointestinal Symptoms Scales
The PedsQL Gastrointestinal Symptoms Scales encompass 10 individual multi-item scales from the PedsQL Gastrointestinal Symptoms Module. 14, 15, 17 To match the Gastrointestinal Symptoms Scales to the concepts being measured by the two Gastrointestinal Worry Scales (i.e., stomach pain and bowel movements), the following three scales were used: Stomach Pain and Hurt Scale (6 items), Constipation Scale (14 items), and Diarrhea Scale (7 items). The format, instructions, Likert response scale, and scoring method are identical to the PedsQL 4.0 Generic Core Scales, 25 so that lower scores demonstrate more (worse) gastrointestinal symptoms and hence lower (worse) gastrointestinal-specific HRQOL. 15 Cronbach's alpha internal consistency reliability coefficients and known-groups validity for the PedsQL Gastrointestinal Symptoms Scales have been previously reported for these pediatric patients with IBD. 14 
PedsQL Gastrointestinal Worry Scales
The PedsQL Gastrointestinal Worry Scales encompass two individual multi-item scales from the PedsQL Gastrointestinal Symptoms Module 14, 15, 17 : (1) Worry About Bowel Movements Scale (5 items, "I worry about going poop in my pants," "I worry that I will not make it to the bathroom in time," "I worry that it will hurt when I go poop," "I worry that I will have to use the bathroom at school," "I worry that I will poop in my pants at school") and (2) Worry About Stomach Aches Scale (2 items, "I worry about my stomach aches," "I worry that my stomach will hurt in school"). Lower scores demonstrate more (worse) gastrointestinal worry and hence lower (worse) gastrointestinal-specific HRQOL. Cronbach's alpha internal consistency reliability coefficients and known-groups validity for the PedsQL Gastrointestinal Worry Scales have been previously reported for these pediatric patients with IBD. 14 
PedsQL Communication Scale
The PedsQL Communication Scale consists of a 5-item scale from the PedsQL Gastrointestinal Symptoms Module ("It is hard for me to tell the doctors and nurses how I feel," "It is hard for me to ask the doctors and nurses questions," "It is hard for me to explain my illness to other people," "It is hard for me to explain my illness to my friends," "It is hard for me to talk to my parents about my illness"). 15 Lower scores demonstrate greater perceived difficulty with health communication. 15 Cronbach's alpha internal consistency reliability coefficients for the PedsQL Communication Scale have been previously reported for pediatric patients with functional and organic gastrointestinal diseases as an overall group. 15 Cronbach's alpha internal consistency reliability coefficient for patients with IBD in the present sample is 0.82, indicating acceptable internal consistency reliability. 26 
PedsQL Generic Core Scales
The 23-item PedsQL 4.0 Generic Core Scales encompass: (1) Physical Functioning Scale (8 items), (2) Emotional Functioning Scale (5 items), (3) Social Functioning Scale (5 items), and (4) School Functioning Scale (5 items). 25 To create the Total Scale Score, the mean is computed as the sum of the items divided by the number of items answered in the Physical, Emotional, Social, and School Functioning Scales. The Total Scale Score measures overall generic HRQOL. 25 Higher scores indicate better overall HRQOL. Cronbach's alpha internal consistency reliability coefficients and known-groups validity for the PedsQL 4.0 Generic Core Scales have been previously reported for these pediatric patients with IBD. 4 
PedsQL Family Information Form
Parents completed the PedsQL Family Information Form which contains demographic information including the child's age, sex, and race/ethnicity information. 25 
Statistical Analysis
Pearson product-moment correlation analyses were conducted to test the bivariate associations between the Gastrointestinal Symptoms Scales, Communication Scale, and Gastrointestinal Worry Scales. Bivariate correlation effect sizes are designated as small (0.10), medium (0.30), and large (0.50) in magnitude. 27 Only variables significantly associated at the bivariate level of analysis were included in subsequent multivariate analyses. Predictive analytics models using multiple regression analyses were conducted to statistically predict the Gastrointestinal Worry criterion variable by the Gastrointestinal Symptoms and Communication Scales after controlling for age, sex, and race/ethnicity demographic variables. 28 Multiple regression analysis is a conservative statistical approach that isolates the effects of a predictor variable on a criterion variable by controlling for the influence of covariates. 28 Hierarchical multiple regression analysis was the statistical procedure for testing the change in the variance accounted for by the Gastrointestinal Symptoms Scales (R 2 change) within the conceptual model. In each hierarchical multiple regression analysis predicting the Gastrointestinal Worry criterion variable, age (continuous variable), sex (coded male ¼ 1, female ¼ 2), and race/ethnicity (dichotomized and coded White non-Hispanic ¼ 1, other race/ethnicity ¼ 0 given the small number of patients identified in some of the race/ethnicity groups) were entered in step 1 as demographic covariates (statistical control variables).
Mediators are intervening variables that are hypothesized to account partially or in full for the relationship between an independent variable and a dependent variable. 29, 30 Conceptually, the independent or predictor variable is hypothesized to have a direct effect on the dependent or outcome variable, as well as a potentially indirect effect through a mediator variable. Empirically identifying the direct and indirect effects of a predictor variable on an outcome or criterion variable enables a test of the possible mechanisms of that prediction, and potentially provides additional targets for interventions. Figure 1 represents a graphical presentation of this hypothesized path model of direct and indirect effects.
A series of multiple regression analyses were conducted to test the conceptual model in which patient communication mediated the relationship between the gastrointestinal symptom and gastrointestinal worry based on the Baron and Kenny conceptual framework. 29 Specifically, we tested the following conceptual path model: gastrointestinal symptom / patient communication / gastrointestinal worry (Fig. 1) . To test for mediating or indirect effects, Baron and Kenny delineated a 4-step analytic method to determine the relationship between the predictor variables and the criterion variable. 29, 30 To support the conceptual model, (1) the gastrointestinal symptom must significantly predict gastrointestinal worry (direct effect), (2) the gastrointestinal symptom must significantly predict patient communication, (3) patient communication must significantly predict gastrointestinal worry controlling for the gastrointestinal symptom, and (4) prediction of gastrointestinal worry by the gastrointestinal symptom must be significantly attenuated when the predictor and proposed mediator are entered simultaneously in the multiple regression analysis. We report standardized regression coefficients (b) and significance levels for steps 1 to 3, and R 2 change for step 4. We used the Sobel test to determine whether the indirect effect through the proposed mediator is significantly different from zero. 31 
The symptom-specific Gastrointestinal Symptoms Scales (either stomach pain, constipation, or diarrhea) are included in models with the symptom-specific Gastrointestinal Worry Scales (either stomach pain worry or bowel movements worry) in separate regression analyses. We report R 2 values for each of the full models. R 2 is the percentage of variability in the criterion variable (gastrointestinal worry mean) explained by the full model (demographic control variables, predictor, mediator). R 2 effect sizes are designated as small (0.02), medium (0.13), and large (0.26) in magnitude. 27 Statistical analyses were conducted using IBM SPSS (Armonk, New York, NY).
We also explored a more complex multiple mediator model. 30 Specifically, we tested the following conceptual path model: gastrointestinal symptom / patient communication / gastrointestinal worry / generic HRQOL (as measured by the PedsQL 4.0 Generic Core Scales Total Scale Score). Indirect effects were tested using 10,000 bias-corrected bootstrapped resamples with replacement yielding 95% confidence intervals (CIs). Significant indirect effects are demonstrated when the 95% CIs do not include zero. These analyses were conducted using the PROCESS macro for SPSS (processmacro.org) as described in Hayes. 32 
RESULTS
Patient Characteristics
A total of 252 pediatric patients with IBD aged 5 to 18 years participated. Patients were diagnosed with either Crohn's disease (n ¼ 188) or ulcerative colitis (n ¼ 64). The average age of the 141 boys (56.0%) and 111 girls (44.0%) was 14.1 years (SD ¼ 2.9). With respect to race/ethnicity, the sample contained 197 (78.2%) White non-Hispanic, 15 (6.0%) Hispanic, 24 (9.5%) Black non-Hispanic, 6 (2.4%) Asian/Pacific Islander, 1 Native American (0.4%), and 9 (3.6%) Other. Table 1 demonstrates the bivariate correlations between the Gastrointestinal Symptoms and Communication Scales with the Gastrointestinal Worry Scales, and with the Generic Core Scales Total Scale Score. All the Gastrointestinal Symptoms and Communication Scales were significantly correlated with the Gastrointestinal Worry Scales (all Ps , 0.001), and these scales were significantly correlated with the Generic Core Scales Total Scale Score (all Ps , 0.001), demonstrating medium-to-large effect sizes.
Bivariate Correlations Between Gastrointestinal Symptoms and Patient Communication with Gastrointestinal Worry
Mediation Analysis Predicting Gastrointestinal Worry
After controlling for age, sex, and race/ethnicity, stomach pain significantly predicted stomach pain worry (b ¼ 0.62, P , 0.001) and patient communication (b ¼ 0.29, P , 0.001), achieving the first 2 criteria for mediation. Patient communication predicted stomach pain worry (b ¼ 0.25, P , 0.001) after controlling for the stomach pain symptom predictor variable, supporting the third criterion for mediation. When stomach pain and patient communication were simultaneously entered into the multiple regression analysis predicting stomach pain worry, the percentage of variance accounted for by stomach pain was attenuated in predicting stomach pain worry (R 2 ¼ 0.38, P , 0.001 versus R 2 ¼ 0.27, P , 0.001), meeting the criteria for partial mediation. The Sobel test indicated that the indirect effect of stomach pain on stomach pain worry was significantly different from zero (Sobel ¼ 3.53, P ¼ 0.0002). The significant attenuation in the magnitude of the association between stomach pain and stomach pain worry when patient communication is controlled signifies that this association is partially mediated or accounted for in part by patient communication. Thus, stomach pain had both direct and indirect effects on stomach pain worry, with the indirect effect partially mediated by patient communication. The full conceptual model accounted for 46% of the variance in stomach pain worry, representing a large effect size. After controlling for age, sex, and race/ethnicity, constipation significantly predicted bowel movements worry (b ¼ 0.63, P , 0.001) and patient communication (b ¼ 0.39, P , 0.001), achieving the first 2 criteria for mediation. Patient communication significantly predicted bowel movements worry (b ¼ 0.17, P ¼ 0.002) after controlling for the constipation symptom predictor variable, achieving the third criterion for mediation. When constipation and patient communication were simultaneously entered into the multiple regression analysis predicting bowel movements worry, the percentage of variance accounted for by constipation was attenuated in predicting bowel movements worry (R 2 ¼ 0.40, P , 0.001 versus R 2 ¼ 0.26, P , 0.001), meeting the criteria for partial mediation. The Sobel test indicated that the indirect effect of constipation on bowel movements worry was significantly different from zero (Sobel ¼ 2.86, P ¼ 0.004). The full conceptual model accounted for 43% of the variance in bowel movement worry, representing a large effect size.
After controlling for age, sex, and race/ethnicity, diarrhea significantly predicted bowel movements worry (b ¼ 0.72, P , 0.001) and patient communication (b ¼ 0.38, P , 0.001), achieving the first 2 criteria for mediation. Patient communication significantly predicted bowel movements worry (b ¼ 0.14, P ¼ 0.004) after controlling for the diarrhea symptom predictor variable, achieving the third criterion for mediation. When diarrhea and patient communication were simultaneously entered into the multiple regression analysis predicting bowel movements worry, the percentage of variance accounted for by diarrhea was attenuated in predicting bowel movements worry (R 2 ¼ 0.52, P , 0.001 versus R 2 ¼ 0.37, P , 0.001), meeting the criteria for partial mediation. The Sobel test indicated that the indirect effect of diarrhea on bowel movement worry was significantly different from zero (Sobel ¼ 2.70, P ¼ 0.0035). The full conceptual model accounted for 54% of the variance in bowel movement worry, representing a large effect size.
Multiple Mediator Model Predicting Generic HRQOL
After controlling for age, sex, and race/ethnicity, the multiple mediator models for stomach pain, constipation, and diarrhea demonstrated that the total indirect effects on overall generic HRQOL as estimated by the sum of the indirect effects for patient health communication and gastrointestinal worry were 0.1073, 0.1900, and 0.2316, respectively, and different from zero as determined by the bias-corrected bootstrap 95% CIs that did not contain zero. Specifically, the indirect effects biascorrected bootstrap 95% CIs for stomach pain, constipation, and diarrhea were all above zero, 0.0436 to 0.1825, 0.1061 to 0.2815, and 0.1532 to 0.3260, respectively. The full conceptual model for stomach pain, constipation, and diarrhea accounted for 42%, 40%, and 37% of the variance in overall generic HRQOL (all Ps , 0.001), respectively, representing large effect sizes.
DISCUSSION
Patient communication was found to partially mediate the relationship between gastrointestinal symptoms and gastrointestinal worry. The overall conceptual model for stomach pain, constipation, and diarrhea accounted for 46, 43, and 54 percent of the variance in patient-reported gastrointestinal worry, respectively, reflecting large effect sizes. These findings support the importance of patient health communication with significant others in their life, including their gastroenterologist, 33, 34 suggesting that the routine standardized assessment of patient health communication in pediatric patients with IBD may be clinically beneficial.
Patient-reported gastrointestinal worrying may be a function of the unpredictability of their gastrointestinal symptoms, worsened by the negative cognitive processes associated with depression and anxiety and the uncertainty of recurrent disease relapses. 13, [35] [36] [37] This study is unique in testing a multivariate predictive model of gastrointestinal worry in pediatric patients with IBD. Using standardized patient-reported multi-item scales to measure gastrointestinal symptoms, patient health communication, and gastrointestinal worry in IBD affords a more systematic approach than only asking patients to verbally report symptoms, worry, and communication about their disease to others.
Worry has been shown in nonclinical samples to be associated with intolerance for uncertainty. [37] [38] [39] [40] The items on the Gastrointestinal Worry Scales reflect this sense of uncertainty or unpredictability of gastrointestinal symptoms, such as, "I worry that I will poop in my pants at school," "I worry that my stomach will hurt in school." Furthermore, research with school-age children has demonstrated that children with higher levels of anxiety and depressive symptoms are more likely to judge the probability of future negative events for themselves higher than children without depressive and anxiety symptoms. 41 Given the generally higher prevalence of anxiety and depressive symptoms in pediatric patients with IBD, 7, 8 and the association of anxiety and depressive symptoms with general worry, 36, 40, 42 it is conceptually consistent to find higher rates of gastrointestinal worry in pediatric patients with IBD compared with healthy controls. 14 The direct effects of patient communication on gastrointestinal worry suggests that patient health communication may be a key target for intervention studies designed to ameliorate gastrointestinal worry and impaired generic HRQOL. 20 Doctorpatient communication may help to manage patient uncertaintythe time of diagnosis and beyond, [46] [47] [48] including follow-up communication not only regarding gastrointestinal symptoms but also emotional concerns even in medically stable patients. 49, 50 This study includes a large sample size for patients with IBD and nationwide representation. Limitations include no information on families who did not participate or information on disease extent, duration, or side effects from therapy. The cross-sectional design limits assumptions of directionality in statistical prediction. Furthermore, we were limited in testing gastrointestinal worry to the 2 worry constructs generated during the qualitative methods item development phase. 16 Finally, the field test database does not contain disease activity indices such as the Pediatric Crohn's Disease Activity Index 51 and the Pediatric Ulcerative Colitis Activity Index. 52 In tertiary care gastroenterology clinical sites such as represented in this study, even if most patients might be expected to experience well-controlled disease, patient worry and symptom uncertainty may be associated not only with IBD but also comorbid conditions such as irritable bowel syndrome and functional abdominal pain, 53, 54 including patients experiencing IBD remission. [55] [56] [57] [58] [59] [60] The occurrence of these recurrent and often unpredictable gastrointestinal symptoms would be anticipated to add to symptom unpredictability and uncertainty, and hence patient gastrointestinal worry, further highlighting the importance of regular patient communication regarding their symptoms. Interventions targeting these functional gastrointestinal symptoms and the emotional distress associated with symptom unpredictability may also reduce patient excessive worry in pediatric patients with IBD, 7, 61 and may potentially positively impact health care utilization such as emergency department visits and hospitalizations. 62 In conclusion, patient health communication represents a novel predictor of gastrointestinal worry in pediatric patients with IBD, serving as a mediating variable explaining part of the relationship between gastrointestinal symptoms and gastrointestinal worry. Encouraging patient disease-specific communication to their health care providers and significant others may improve HRQOL for pediatric patients with IBD. Targeting patient health communication and gastrointestinal worry simultaneously may be beneficial in ameliorating impaired HRQOL in IBD. 
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